Advanced search
Publication Cover
OncoImmunology Volume 2, 2013 - Issue 8
Submit an article Journal homepage
587
Views
5
CrossRef citations to date
0
Altmetric
Point of View

Biological insights into BRAFV600 mutations in melanoma patient

Not mere therapeutic targets

Giuseppina Improta Laboratory of Clinical Research and Molecular Diagnostics; IRCCS - CROB Centro di Riferimento Oncologico della Basilicata; Rionero in Vulture (Pz), Italy
,
Giuseppe Pelosi Department of Pathology and Laboratory Medicine; Fondazione IRCCS Istituto Nazionale Tumori; Milan, Italy; Department of Biomedical and Clinical Sciences “Luigi Sacco”; Università degli Studi; Milan, Italy
,
Elena Tamborini Department of Pathology and Laboratory Medicine; Fondazione IRCCS Istituto Nazionale Tumori; Milan, Italy
,
Marco Donia Center for Cancer Immune Therapy; Department of Haematology; Copenhagen University Hospital Herlev; Herlev, Denmark; Department of Biomedical Sciences; University of Catania; Catania, Italy
,
Mario Santinami Melanoma Sarcoma Unit; Fondazione IRCCS Istituto Nazionale dei Tumori; Milano, Italy
,
Filippo de Braud Department of Medical Oncology; Fondazione IRCCS Istituto Nazionale Tumori; Milano, Italy
&
Filippo Fraggetta Pathology Unit; Cannizzaro Hospital; Catania, ItalyCorrespondence[email protected]
 show all
Article: e25594 | Received 25 Jun 2013, Accepted 28 Jun 2013, Published online: 03 Jul 2013

References

  • Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al. Mutations of the BRAF gene in human cancer. Nature 2002; 417:949 - 54; http://dx.doi.org/10.1038/nature00766; PMID: 12068308
  • Sosman JA, Kim KB, Schuchter L, Gonzalez R, Pavlick AC, Weber JS, et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med 2012; 366:707 - 14; http://dx.doi.org/10.1056/NEJMoa1112302; PMID: 22356324
  • Donia M, Hansen M, Sendrup SL, Iversen TZ, Ellebæk E, Andersen MH, et al. Methods to improve adoptive T-cell therapy for melanoma: IFN-γ enhances anticancer responses of cell products for infusion. J Invest Dermatol 2013; 133:545 - 52; http://dx.doi.org/10.1038/jid.2012.336; PMID: 23014345
  • Cangemi G, Morandi B, D’Agostino A, Peri C, Conte R, Damonte G, et al. IFN-alpha mediates the up-regulation of HLA class I on melanoma cells without switching proteasome to immunoproteasome. Int Immunol 2003; 15:1415 - 21; http://dx.doi.org/10.1093/intimm/dxg140; PMID: 14645150
  • Sapkota B, Hill CE, Pollack BP. Vemurafenib enhances MHC induction in BRAF(V600E) homozygous melanoma cells. Oncoimmunology 2013; 2:e22890; http://dx.doi.org/10.4161/onci.22890; PMID: 23483066
  • Rubinstein JC, Sznol M, Pavlick AC, Ariyan S, Cheng E, Bacchiocchi A, et al. Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032. J Transl Med 2010; 8:67; http://dx.doi.org/10.1186/1479-5876-8-67; PMID: 20630094
  • Sigalotti L, Fratta E, Parisi G, Coral S, Maio M. Stability of BRAF V600E mutation in metastatic melanoma: new insights for therapeutic success?. Br J Cancer 2011; 105:327 - 8; http://dx.doi.org/10.1038/bjc.2011.239; PMID: 21694724
  • Jönsson G, Dahl C, Staaf J, Sandberg T, Bendahl PO, Ringnér M, et al. Genomic profiling of malignant melanoma using tiling-resolution arrayCGH. Oncogene 2007; 26:4738 - 48; http://dx.doi.org/10.1038/sj.onc.1210252; PMID: 17260012
  • Tanami H, Imoto I, Hirasawa A, Yuki Y, Sonoda I, Inoue J, et al. Involvement of overexpressed wild-type BRAF in the growth of malignant melanoma cell lines. Oncogene 2004; 23:8796 - 804; http://dx.doi.org/10.1038/sj.onc.1208152; PMID: 15467732
  • Tischfield JA. Loss of heterozygosity or: how I learned to stop worrying and love mitotic recombination. Am J Hum Genet 1997; 61:995 - 9; http://dx.doi.org/10.1086/301617; PMID: 9345110

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.